Physician profile
Bruce Kallou
NPI 1578806253
$10,110.30
in general payments reported to CMS, 2019-2025
45 companies · $1,259 in 2025
The $1,259 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,365 · 2020: $387 · 2021: $2,308 · 2022: $2,479 · 2023: $1,438 · 2024: $875 · 2025: $1,259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,571.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,672.22 | 2019-2025 | Augment Injectable, Citrefix, Prostep |
| Pinnacle, INC | $1,310.10 | 2021-2024 | |
| Smith+Nephew, INC. | $1,209.33 | 2019-2024 | Collagenase Santyl, Pico 7 |
| Organogenesis INC. | $648.71 | 2019-2025 | Puraply, Affinity, Apligraf |
| Treace Medical Concepts, INC. | $635.68 | 2021-2025 | |
| Abbvie INC. | $318.12 | 2021-2025 | |
| Aroa Biosurgery Incorporated | $301.73 | 2022-2024 | |
| Inari Medical, INC. | $245.76 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Integra Lifesciences Corporation | $234.10 | 2019-2023 | Integra, Tenoglide, Integra Dermal Regeneration Template |
| Paratek Pharmaceuticals, INC. | $207.53 | 2022-2024 | Nuzyra |
| Paragon 28, INC. | $200.68 | 2019-2025 | R3flex |
| Depuy Synthes Sales INC. | $157.94 | 2022-2024 | Motoband |
| Mimedx Group, INC. | $154.67 | 2025 | |
| Biotissue Holdings INC. | $143.87 | 2023 | |
| Horizon Therapeutics Plc | $137.21 | 2019-2021 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ets Wound Care LLC | $133.27 | 2025 | Mirragen Advanced Wound Matrix |
| Biopoly LLC | $129.25 | 2023 | |
| Surgenex LLC | $112.74 | 2025 | Surmatrix, Pellograft, Renograft |
| Acumed LLC | $100.00 | 2019-2024 | Acumed, Osteomed |
| Musculoskeletal Transplant Foundation INC. | $96.20 | 2019 | |
| Kerecis Limited | $84.67 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Graftguide |
| Bioventus LLC | $84.64 | 2019-2020 | |
| Pfizer INC. | $68.78 | 2019-2020 | |
| Kci USA, INC. | $54.39 | 2019-2023 | Snap, Activ.A.C. |
| Medshape, INC. | $53.14 | 2023 | Dynanail Helix, Washer, 15 Mm, Dynanail, Dynanail Hybrid |
| Zimmer Biomet Holdings, INC. | $52.70 | 2022 | |
| Merck Sharp & Dohme LLC | $50.19 | 2019 | |
| Boston Scientific Corporation | $48.24 | 2023-2025 | Wavewriter Alpha Prime 16 |
| Grt US Holding, INC. | $45.71 | 2022 | |
| Osteomed LLC | $41.91 | 2022 | |
| Axogen | $39.46 | 2021-2025 | Axoguard Ha+ Nerve Protector |
| Mallinckrodt Hospital Products INC. | $37.86 | 2020 | |
| Next Science LLC | $36.33 | 2023 | Xperience, Blastx, Surgx |
| Mallinckrodt Enterprises LLC | $33.52 | 2019 | |
| Nevro Corp. | $29.90 | 2023 | Senza |
| Cardiovascular Systems INC. | $26.28 | 2019 | |
| Convatec INC. | $25.10 | 2025 | |
| Heron Therapeutics, INC. | $24.54 | 2025 | Zynrelef |
| Crossroads Extremity Systems, LLC | $21.55 | 2020 | |
| Ibsa Pharma INC. | $21.40 | 2023 | Tirosint, Licart |
| Orthofix Medical, INC. | $18.27 | 2019-2020 | |
| Acell, INC. | $18.02 | 2019 | |
| Arthrosurface Incorporated | $17.00 | 2019 | |
| Solventum Corporation | $15.19 | 2025 | Activ.A.C., Promogran Prisma |
| Melinta Therapeutics, LLC | $12.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Kallou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.